The frequency of HLA-DR antigens was studied in 54 patients with mumps meningitis, and in two control groups. The first control group comprised 333 randomly chosen subjects while the second group was composed of 46 subjects who have passed mumps without meningitis. The DR5 antigen was more frequent in patients than in the second control group with relative risk of 2.4 and significance at the level of p < 0.05. The p value became insignificant after the correction for the number of antigens investigated.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Unsupported walking with only half of the brain due to severe porencephaly.
J Family Med Prim Care
December 2024
Neurology Neurophysiology Center, Vienna, Austria.
A patient with a history of Asian flu, mumps meningo-encephalitis, and skull-base fracture and severe porencephaly who was able to walk without assistance, has not been reported. The patient is a 65 year-old male with a history of Asian flu at 6 months of age, Mumps meningoencephalitis at 6 years of age, structural epilepsy since 15 years of age, traumatic brain injury with skull-base fracture at 51 years of age, arterial hypertension, diabetes, hyperlipidemia, previous alcoholism, and polyneuropathy. He presented with only mild right-sided spastic hemiparesis, dysarthria, decreased tendon reflexes in the lower limbs, spastic-ataxic gait, but he was able to walk unassisted.
View Article and Find Full Text PDFA case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination.
Allergy Asthma Proc
November 2024
From the Division of Allergy and Immunology and.
We present a case of a 12-year-old healthy girl who presented with acute onset of dry, hyperpigmented, and raised pruritic rash. The lesions initially presented on her thighs then progressed to the trunk and arms hours after receiving the tetanus-diphtheria-pertussis (Tdap) and meningococcal vaccine. After a poor response to medium potency topical steroids, a biopsy specimen was taken, which led to our diagnosis.
View Article and Find Full Text PDFAtypical Mumps; are We Heading Towards an Outbreak?
Indian J Otolaryngol Head Neck Surg
October 2024
AIIMS, Bhubneshwar, India.
Article Synopsis
- Mumps is a contagious disease mainly affecting children and young adults, characterized by salivary gland swelling and potential serious complications like SNHL, orchitis, and meningitis.
- A recent study conducted in five medical centers across India examined 53 patients with acute salivary gland swelling, revealing a bimodal age distribution and significant symptoms such as fever and gland involvement.
- The findings indicate a concerning trend of mumps affecting older individuals with increased complications post-COVID-19, highlighting issues related to vaccination, immunity, and the potential for outbreaks in the future.
Vaccination Against Mumps, Aren't We Late Already?
JNMA J Nepal Med Assoc
July 2024
Dhading hospital, Dhadingbesi, Dhading, Nepal.
Article Synopsis
- Mumps is a viral infection characterized by fever and swelling of the parotid glands, caused by the paramyxovirus.
- Complications from mumps can include aseptic meningitis, encephalitis, oophoritis, orchitis, and pancreatitis.
- The rising incidence of mumps in Nepal highlights the need to include mumps vaccination in the national immunization schedule.
Monitoring the Effect of Vaccination on Mumps Cases Complications in the Czech Republic - Surveillance Data 2013-2022.
Zdr Varst
December 2024
National Institute of Public Health, Centre for Epidemiology and Microbiology, Šrobárova 49/48, 100 00 Prague 10, Czech Republic.
Introduction: Mumps data were analysed to assess the effect of vaccination on mumps complications and hospitalisation.
Methods: The mumps cases reported to the Czech nationwide surveillance system from 2013 to 2022 were analysed using logistic regression with an odds ratio (aOR) adjusted for age, sex, year of onset and administrative region to measure the association between vaccination and complications or hospitalisation. Adjusted vaccine effectiveness (aVE) was calculated: aVE=(1-aOR)x100.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!